![Biosense Webster receives CE mark for VARIPULSE PFA Platform](https://startllc.com/wp-content/uploads/2024/03/VARIPULSE-Platform-Image-1-300x138.jpg)
Biosense Webster receives CE mark for VARIPULSE PFA Platform
Biosense Webster, a cardiac arrhythmia treatment specialist and part of Johnson & Johnson MedTech, has received CE mark approval for the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA).